Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03411135
Recruitment Status : Completed
First Posted : January 26, 2018
Last Update Posted : January 26, 2018
Sponsor:
Information provided by (Responsible Party):
Maha Fathy Elmasry, Cairo University

Brief Summary:
All patients with vitiligo attending dermatology outpatient clinic at Kasr Alainy Teaching Hospital will be enrolled in this study to compare VES and VASI scores and evaluate them as assessment methods

Condition or disease Intervention/treatment
Vitiligo Other: VES and VASI scores as assessment methods for vitiligo

Layout table for study information
Study Type : Observational
Actual Enrollment : 101 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: In-depth Analysis of the Implementation of Vitiligo Extent Score (VES) Score in Comparison to Vitiligo Area and Severity Index (VASI) Score
Actual Study Start Date : April 2016
Actual Primary Completion Date : September 2016
Actual Study Completion Date : September 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Vitiligo


Intervention Details:
  • Other: VES and VASI scores as assessment methods for vitiligo
    compare VES and VASI scores as assessment methods for vitiligo


Primary Outcome Measures :
  1. The evaluation of the use of vitiligo extent score (VES) as a scoring system for vitiligo [ Time Frame: 6 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Vitiligo patients presenting to dermatology outpatient clinic at Kasr Alainy Teaching Hospital.
Criteria

Inclusion Criteria:

  • Age > 18.
  • Non-segmental vitiligo patients

Exclusion Criteria:

  • Age < 18
  • Segmental vitiligo

Layout table for additonal information
Responsible Party: Maha Fathy Elmasry, principal investigator, Cairo University
ClinicalTrials.gov Identifier: NCT03411135     History of Changes
Other Study ID Numbers: Dermatology6
First Posted: January 26, 2018    Key Record Dates
Last Update Posted: January 26, 2018
Last Verified: January 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Vitiligo
Hypopigmentation
Pigmentation Disorders
Skin Diseases